United States Immunization Schedule

United States Immunization Schedule
Name	United States Immunization Schedule
Caption	Routine immunization timeline for children, adolescents, and adults
Jurisdiction	United States
Responsible agency	Centers for Disease Control and Prevention
First issued	1991
Latest revision	2024

United States Immunization Schedule The national immunization schedule coordinates routine vaccination timing across pediatric, adolescent, and adult populations under federal and state systems, aligning recommendations from the Centers for Disease Control and Prevention, the Advisory Committee on Immunization Practices, and professional societies to reduce vaccine-preventable diseases. The Schedule integrates guidance from the American Academy of Pediatrics, the American Academy of Family Physicians, and state immunization programs while reflecting evidence from clinical trials, observational studies, and surveillance by the Food and Drug Administration and the World Health Organization.

Overview

The Schedule is maintained by the Centers for Disease Control and Prevention with input from the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, and the American Academy of Family Physicians to provide age-based and risk-based recommendations for vaccines such as diphtheria–tetanus–pertussis, measles–mumps–rubella, and influenza. It is distributed annually alongside catch-up schedules and special population guidance for pregnant persons, immunocompromised individuals, and travelers, coordinated with the Food and Drug Administration licensure decisions, the National Institutes of Health research priorities, and state-level implementation by departments of health. The Schedule informs clinical practice in hospitals like Johns Hopkins Hospital, public health clinics affiliated with Kaiser Permanente, and community health centers supported by the Health Resources and Services Administration.

History and Development

Development traces to early 20th century campaigns against smallpox and diphtheria led by entities such as the United States Public Health Service and landmark legislation like the Vaccination Assistance Act of 1962 and the Public Health Service Act. The modern CDC pediatric schedule emerged as vaccination complexity increased with introduction of vaccines for hepatitis B, varicella, and pneumococcal disease, influenced by vaccine licensure decisions at the Food and Drug Administration and immunization policy reviews by the Advisory Committee on Immunization Practices. Key public health events—such as the 1955 Cutter incident, the 1998 Wakefield controversy, and the 2009 H1N1 influenza pandemic—shaped surveillance, safety monitoring by the Vaccine Adverse Event Reporting System, and communication strategies used by the Centers for Disease Control and Prevention and the Institute of Medicine (now National Academy of Medicine). State school-entry laws, court rulings, and federal programs like Vaccines for Children Program institutionalized enforcement and access.

Recommended Schedules and Age-specific Guidance

Recommendations are organized into pediatric, adolescent, and adult schedules with specific timing for doses at birth, 2, 4, 6, 12–15, and 4–6 years for children, and tailored adolescent recommendations at 11–12 years and 16 years, reflecting guidance for vaccines such as hepatitis B, rotavirus, diphtheria–tetanus–pertussis, and human papillomavirus. Adult guidance covers routine boosters, seasonal influenza recommendations from the Advisory Committee on Immunization Practices, and special recommendations for older adults and pregnant persons based on evidence synthesized by the National Institutes of Health and professional bodies like the American College of Obstetricians and Gynecologists. Catch-up schedules and accelerated schedules are provided for refugees, displaced persons, and travelers in consultation with agencies such as the Department of State and the Centers for Disease Control and Prevention travel health services.

Vaccine-specific Recommendations

The Schedule details vaccine-specific guidance for inactivated and live-attenuated products including measles–mumps–rubella, varicella, pneumococcal conjugate, meningococcal, hepatitis A, hepatitis B, influenza (inactivated and live intranasal), rotavirus, human papillomavirus, and zoster vaccines. Recommendations reflect clinical trial outcomes and post-licensure studies reviewed by the Food and Drug Administration and the Advisory Committee on Immunization Practices with input from clinical societies like the Infectious Diseases Society of America and the American Academy of Pediatrics. Specific contraindications and precautions align with safety assessments by the Vaccine Adverse Event Reporting System and vaccine injury considerations under the National Vaccine Injury Compensation Program.

Implementation and Delivery (Providers and Programs)

Implementation relies on primary care providers, pediatricians in practices affiliated with the American Academy of Pediatrics, family physicians in networks such as Kaiser Permanente, public health clinics funded by the Health Resources and Services Administration, and immunization programs run by state departments of health. Federal programs including the Vaccines for Children Program and the Centers for Medicare & Medicaid Services reimburse vaccine services and influence uptake in Medicaid and Medicare populations, while school-entry requirements enforced by state legislatures and departments of education ensure compliance for school-aged children. Data systems like the Immunization Information Systems coordinated through the Centers for Disease Control and Prevention and statewide registries support reporting, reminders, and surveillance.

Coverage, Uptake, and Public Health Impact

Uptake metrics from national surveys and surveillance compiled by the Centers for Disease Control and Prevention show high coverage for many childhood vaccines but variable uptake for influenza and human papillomavirus vaccines, with disparities documented by the Kaiser Family Foundation, the National Center for Health Statistics, and academic centers such as Harvard T.H. Chan School of Public Health. Implementation of the Schedule has driven sustained reductions in morbidity and mortality from measles, rubella, diphtheria, pertussis, invasive pneumococcal disease, and hepatitis B documented in peer-reviewed studies involving institutions like Johns Hopkins University and Stanford University School of Medicine. Outbreak responses, vaccine effectiveness studies, and economic analyses by the Centers for Disease Control and Prevention and the Office of Management and Budget quantify benefits and guide policy.

Policy, Regulation, and Advisory Bodies

Policy formation involves the Advisory Committee on Immunization Practices, regulatory evaluation by the Food and Drug Administration, and implementation oversight by the Centers for Disease Control and Prevention in coordination with the Department of Health and Human Services, state health departments, and professional organizations such as the American Academy of Pediatrics and the American Medical Association. Legal and ethical frameworks intersect with statutes like the Public Health Service Act and programs administered by the Health Resources and Services Administration, while independent reviews by the National Academy of Medicine and litigation in federal courts can influence mandates, exemptions, and compensation under the National Vaccine Injury Compensation Program.

Category:Vaccination in the United States